Francesca Crupi

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Clinical Experience With Venetoclax-Based Combinations for Relapsed/Refractory or MRD-Positive NPM1-Mutated Acute Myeloid Leukemia.

Clinical Experience With Venetoclax-Based Combinations for Relapsed/Refractory or MRD-Positive NPM1-Mutated Acute Myeloid Leukemia.

Journal: American journal of hematology

Published: March 16, 2026

Venetoclax and gilteritinib combination for FLT3-mutated relapsed/refractory acute myeloid leukemia: a real-world single-center experience.

Venetoclax and gilteritinib combination for FLT3-mutated relapsed/refractory acute myeloid leukemia: a real-world single-center experience.

Journal: Haematologica

Published: February 09, 2026

APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.

APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.

Journal: HemaSphere

Published: September 15, 2025

Defining "Normal" basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis.

Defining "Normal" basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis.

Journal: Frontiers in allergy

Published: March 11, 2025

Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.

Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.

Journal: Blood cancer journal

Published: December 17, 2024

Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting.

Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting.

Journal: Haematologica

Published: June 10, 2024

Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.

Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.

Journal: Hematological oncology

Published: April 29, 2024

Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report.

Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report.

Journal: Therapeutic advances in hematology

Published: November 09, 2023

The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.

The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.

Journal: Therapeutic advances in hematology

Published: June 17, 2023

Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia.

Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia.

Journal: Haematologica

Published: March 24, 2023

Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy.

Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy.

Journal: Leukemia research

Published: February 20, 2023

Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.

Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.

Journal: International journal of molecular sciences

Published: May 22, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026